Champions Oncology, Inc.CSBRNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
30.40%
↑ 178% vs avg
Percentile
P56
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-39.15%
Historical baseline
| Period | Value |
|---|---|
| Q1 2026 | 30.40% |
| Q4 2025 | -456.86% |
| Q3 2025 | -91.63% |
| Q2 2025 | 1376.56% |
| Q1 2025 | 218.83% |
| Q4 2024 | -221.22% |
| Q3 2024 | 118.24% |
| Q2 2024 | -63.16% |
| Q1 2024 | -339.68% |
| Q4 2023 | 109.36% |
| Q3 2023 | -217.15% |
| Q2 2023 | -279.37% |
| Q1 2023 | -69.46% |
| Q4 2022 | 382.61% |
| Q3 2022 | -427.24% |
| Q2 2022 | -92.47% |
| Q1 2022 | 481.87% |
| Q4 2021 | 195.80% |
| Q3 2021 | 75.62% |
| Q2 2021 | -165.36% |
| Q1 2021 | -386.33% |
| Q4 2020 | 126.03% |
| Q3 2020 | -240.77% |
| Q2 2020 | 842.59% |
| Q1 2020 | -81.60% |
| Q4 2019 | 157.10% |
| Q3 2019 | -1026.13% |
| Q2 2019 | -88.93% |
| Q1 2019 | 575.36% |
| Q4 2018 | -268.80% |
| Q3 2018 | 161.58% |
| Q2 2018 | -154.72% |
| Q1 2018 | 57.20% |
| Q4 2017 | 108.26% |
| Q3 2017 | -1428.34% |
| Q2 2017 | 76.60% |
| Q1 2017 | -436.24% |
| Q4 2016 | 93.97% |
| Q3 2016 | -231.68% |
| Q2 2016 | 13.17% |